MGMT – TMZ Response — SCE Neurology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — MGMT promoter methylation predicts better response to temozolomide — the silenced repair enzyme cannot counteract TMZ-induced DNA damage, increasing tumour cell death (median survival ~22 months vs ~15 months)
MGMT methylation epigenetically silences the DNA repair enzyme, making the tumour more sensitive to alkylating chemotherapy (TMZ). Major prognostic and predictive biomarker. A: Significant. C: Still grade 4. D: Predicts better response. E: No radiation resistance link.
Reference: NICE NG99; Hegi et al. NEJM 2005